
pmid: 12497000
Vascular endothelial growth factor (VEGF) is a heparin-binding polypeptide growth factor. It is a potent mitogen for endothelial cells. Immunohistochemical localisation of VEGF was performed on 25 moderate to poorly differentiated stage T4 M+ prostate cancer specimens and 30 benign prostatic hyperplasia (BPH) specimens. A positive result was indicated by area staining >25% and +2 or +3 staining intensity. Positive epithelial staining was observed in 50% of BPH specimens and 56% of cancer specimens, while positive stromal staining was observed in 73% of BPH specimens and 30% of cancer specimens. This may reflect an active role for stromal VEGF in the pathological process of BPH.
Male, Vascular Endothelial Growth Factor A, Lymphokines, Vascular Endothelial Growth Factors, Prostatic Hyperplasia, Humans, Intercellular Signaling Peptides and Proteins, Prostatic Neoplasms, Endothelial Growth Factors, Immunohistochemistry
Male, Vascular Endothelial Growth Factor A, Lymphokines, Vascular Endothelial Growth Factors, Prostatic Hyperplasia, Humans, Intercellular Signaling Peptides and Proteins, Prostatic Neoplasms, Endothelial Growth Factors, Immunohistochemistry
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 28 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
